Ionis Pharmaceuticals, Inc. Common Stock (IONS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for IONS. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 170 institutions reported holding IONS, with 80.1 million shares worth $3.6 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 24,740,108 | $1.1B | INCREASED |
| BlackRock | 13,192,834 | $589M | INCREASED |
| Vanguard | 8,790,658 | $393M | DECREASED |
| State Street | 5,710,900 | $255M | INCREASED |
| Geode Capital Management | 3,277,569 | $146M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Michael R Hayden (Director) | BUY | 5,000 | $148K | 2026-11-10 |
| Shannon L. Devers (EVP, Chief Human Resources Ofc) | SELL | 1,357 | $59K | 2026-10-16 |
| Eric Swayze (EVP Research) | SELL | 53 | $2K | 2026-10-16 |
| Shannon L. Devers (EVP, Chief Human Resources Ofc) | EXERCISE | 2,820 | 2026-10-15 | |
| Shannon L. Devers (EVP, Chief Human Resources Ofc) | EXERCISE | 2,820 | 2026-10-15 |
Full institutional holdings, insider history, and congressional trades for Ionis Pharmaceuticals, Inc. Common Stock on SentiSense.